U.S. Markets close in 5 hrs 53 mins

Global Wellness Strategies Inc. (O3X.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
0.0480-0.0005 (-1.03%)
As of 08:01AM CET. Market open.
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0485
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's Range0.0480 - 0.0480
52 Week Range0.0060 - 0.2320
Avg. Volume1,286
Market Cap1.133M
Beta (5Y Monthly)-1.48
PE Ratio (TTM)N/A
EPS (TTM)-0.0690
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    Global Wellness Pharma Subsidiary Supports Cancer Therapeutic Company AVM Biotechnology

    Vancouver, British Columbia--(Newsfile Corp. - December 5, 2022) - Global Wellness Strategies Inc. (CSE: GWS) (FSE: O3X) (OTCQB: GWSFF) ("Global Wellness" or the "Company") pharma subsidiary is excited to work with BioMed360 a GWS medical advisor.GWS pharma subsidiary is focused on providing companies with financial, operational, and management assistance during their clinical trials phase. GWS announces that BioMed360 Solutions Corp signed a letter of intent for the 100% acquisition of AVM Biot

  • Newsfile

    Global Wellness Strategies Forms Pharma Subsidiary Focused on Clinical Trials

    Vancouver, British Columbia--(Newsfile Corp. - November 17, 2022) - Global Wellness Strategies Inc. (CSE: GWS) (FSE: O3X) (OTCQB: GWSFF) ("Global" or the "Company") a prospect generator that provides high growth companies with financial, operational, and management assistance focused in health and wellness announces the formation of a wholly owned pharma subsidiary focused on clinical trials."Real strategic capital market partnerships are essential to assist our clients in their progression to t

  • Newsfile

    Global Wellness Corporate Quarter Highlights

    Vancouver, British Columbia--(Newsfile Corp. - June 27, 2022) - Global Wellness Strategies Inc. (CSE: GWS) (FSE: O3X4) (OTCQB: GWSFF) ("Global" or the "Company") provides quarter corporate highlights.The Company quarter corporate highlights included announcing:May 12th that Global Wellness' Shanti Therapeutics was preparing for their first clinical trial with iNGENü a subsidiary of Australian leader Cannvalate. Shanti' s product suite of MDMA could be the global market winner finding a solution